Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Coherus Oncology (CHRS) Receivables - Other (2016 - 2025)

Coherus Oncology's Receivables - Other history spans 5 years, with the latest figure at $603000.0 for Q4 2025.

  • For Q4 2025, Receivables - Other fell 94.52% year-over-year to $603000.0; the TTM value through Dec 2025 reached $603000.0, down 94.52%, while the annual FY2025 figure was $603000.0, 94.52% down from the prior year.
  • Receivables - Other for Q4 2025 was $603000.0 at Coherus Oncology, down from $241.3 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $241.3 million in Q3 2025 and bottomed at $603000.0 in Q4 2025.